Skip to main content
Clinical Trials/EUCTR2010-024402-35-GB
EUCTR2010-024402-35-GB
Active, Not Recruiting
Phase 1

Clinical effectiveness of Transversus Abdominis Plane (TAP) block as postoperative analgesic in patients undergoing laparoscopic colorectal surgery: a double blinded randomised controlled trial - Effective pain relief following laparoscopic colorectal surgery

Sussex NHS Research Consortium0 sites80 target enrollmentApril 2, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Pain relief following laparoscopic colorectal resectional surgery (Benign and malignant)
Sponsor
Sussex NHS Research Consortium
Enrollment
80
Status
Active, Not Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 2, 2012
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Sussex NHS Research Consortium

Eligibility Criteria

Inclusion Criteria

  • Inclusion Criteria: All patients undergoing elective laparoscopic colorectal resectional procedures Patients undergoing colorectal procedure with or without stoma Patients of either sex Adult patients above 16 years of age Patients of any BMI Patients who have had neoadjuvant radiotherapy or chemoradiotherpay Patients of ASA I, ASA II and ASA III anaesthetic risk Patients who agree and sign the consent form to participate in this trial.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 40
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 50

Exclusion Criteria

  • Exclusion Criteria: Patients unable to give consent or refuse to participate in this study Patients under the age of 16 years Patients who are pregnant Patients undergoing an emergency operation Patients undergoing the procedure as a postoperative complication Procedures performed for complications or adverse events during the same hospital episode or performed in circumstances related to a primary and initial procedure. Patient is allergic to any medication used in local infiltration and/or morphine Patients with chronic pain syndrome Patients with severe hypotension such as cardiogenic or hypovolaemic shock Patients with severe hypertension.

Outcomes

Primary Outcomes

Not specified

Similar Trials